Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8207187 Use of pyrroloquinoline compounds to kill clinically latent microorganisms

Patent 8207187 was granted and assigned to Helperby Therapeutics on June, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Helperby Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82071870

Patent Inventor Names

Thomas David Pallin0

Yanmin Hu0

Gary Patrick Reid0

Anthony Coates0

David Edward Clark0

Derek John Londesbrough0

Gerlinda Stoddart0

Hazel Joan Dyke0

...

Date of Patent

June 26, 2012

Patent Application Number

120929470

Date Filed

November 8, 2006

Patent Citations Received

‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

‌

US Patent 12077539 Imidazole and triazole KRAS inhibitors

‌

US Patent 11999752 Vinyl imidazole compounds as inhibitors of KRAS

‌

US Patent 11939328 Quinoline compounds as inhibitors of KRAS

Patent Primary Examiner

‌

Sharmila G. Landau

Patent abstract

There is provided the use of compounds of formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8207187 Use of pyrroloquinoline compounds to kill clinically latent microorganisms

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API